Patent Assistant
BSc Biological Chemistry, University of Dundee
PhD Medicinal Chemistry and Drug Discovery, University of Dundee
Thank you
Eleanor graduated from the University of Dundee in 2018 with a first-class honours degree in Biological Chemistry and Drug Discovery. During this time, she developed a keen interest in medicinal chemistry and early-phase drug development. In 2016, she won the University’s Carnelly Prize for a proficiency in chemistry, along with the Graham Smith Prize for achieving the highest grades in her degree stream. Her dissertation was focused on synthesising covalent fragments for use in fragment-based drug discovery.
Eleanor then completed an interdisciplinary PhD in Antibacterial Drug Discovery. Her research was focused on the development of chemical probes for use in mode of action studies in Gram-negative bacteria. During her PhD, she gained experience in organic synthesis, medicinal chemistry, biochemistry, drug discovery and bacterial molecular biology.
Eleanor joined Keltie in July 2023 and is training to become a qualified UK and European Patent Attorney.
![Recap of Emotional Perception AI v. Comptroller-General of Patent, Designs and Trade Marks [2023]](https://www.keltie.com/images/knowledge/-main-1720625740.jpg)
10.07.2024
Recap of Emotional Perception AI v. Comptroller-General of Patent, Designs and Trade Marks [2023]The case of Emotional Perception AI v. Comptroller-General of Patent, Designs and Trade Marks concerns a patent application in the field of artificial neural networks (ANNs) that after several rounds of Examination has resulted in two court appeals to date. In the lead-up to the handing down of the judgement from the Court of Appeal (England and Wales), we provide a recap of the case to date.
02.04.2024
Patents, plausibility and data: one year on from G 2/21On 23 March 2023, the European Patent Office (EPO) Enlarged Board of Appeal (EBA) published its decision in case G 2/21, concerning plausibility in patent applications. The decision provided useful guidance on how much data needs to be disclosed in a patent application to overcome objections based on the grounds of lack of inventive step and insufficiency. One year on, we take a look at how the EPO has been applying this standard in the life sciences field.
22.11.2023
What is Quantum Computing? Part II09.08.2023
Take your rest this AugustOtherLess related knowledge
Thank you
